Aims: To describe the prevalence of hyperhomocystein- emia (>15 µmol/l) in hospitalized elderly and to investigate whether nutrition status and other factors are related to total plasma homocysteine (tHcy). Methods: Sixty hospitalized elderly patients (age 83.0 ± 7.9 years) participated in this cross-sectional study. Blood was drawn in fasting state and analyzed for albumin, prealbumin, lymphocytes, tHcy, cystatin C, folic acid, and vitamin B12. The nutritional status was assessed. Statistical analyses included multivariate regression. Results: The prevalence of hyperhomocysteinemia was 31.7%, increased cystatin C was observed in 38.3% of the subjects. tHcy correlated positively with cystatin C, but negatively with vitamin B12 and folic acid. Neither age nor nutritional status were related to tHcy. In multivariate analysis, folic acid and cystatin C remained significant predictors of tHcy (adjusted R2 = 60.6%). According to the regression model, serum folic acid concentrations >30.3 nmol/l are required to achieve a mean tHcy <15.0 µmol/l in patients with reduced renal function. Conclusions: Hyperhomocysteinemia is frequent in hospitalized elderly. Cystatin C and folic acid explain most of the tHcy variance. Higher folic acid levels within the normal range might further decrease tHcy. The current lower folic acid cutoff value (7 nmol/l) might not be sufficient in preventing homocysteinemia in hospitalized elderly with reduced renal function.

Keywords:
Homocysteine, Folic acid, Vitamin B12, Nutritional status, hospitalized elderly
This content is only available via PDF.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.